#63 Medical Marijuana: Is it really dope?

The Curbsiders Internal Medicine Podcast

Health & Fitness, Medicine, Science, Higher Education, Education

4.8 • 3.1K Ratings

🗓️ 23 October 2017

⏱️ 51 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

Expand your consciousness around medical cannabis (aka marijuana) with expert Dr Donald Abrams, Chief of the Hematology-Oncology Division at San Francisco General Hospital and a Professor of Clinical Medicine at the University of California San Francisco. We explain the cannabinoid system, THC, CBD aka cannabidiol, limitations surrounding cannabis research, current and future medical uses for medical cannabis (marijuana), and potential conditions it may benefit. We take a deep dive on the potential harms of medical cannabis and how to counsel patients on safe use. Plus, the return past guest and new correspondent, Dr Molly Heublein, Assistant Professor of Medicine from UCSF.

Thanks to Dr Molly Heublein for writing and producing this episode and it’s show notes!

Full show notes available at http://thecurbsiders.com/podcast

Join our mailing list and receive a PDF copy of our show notes every Monday. Rate us on iTunes, recommend a guest or topic and give feedback at [email protected].

Clinical case from Kashlak Memorial: MM is a 62 yo woman with a history of osteoarthritis and breast cancer, now on an aromatase inhibitor. She struggles with aching and stiffness in her hands, shoulders, knees, and hips. A friend suggested she try medical marijuana. She wants her provider’s opinion on if this is safe and effective.

Time Stamps

00:00 Intro

01:30 Picks of the week

03:40 Guest bio

05:11 Getting to know our guest

11:03 Clinical case

11:40 Limitations for cannabis research

12:59 Discussion of THC and cannabidiol

14:50 Smoking versus ingesting cannabis products

16:40 Recap of cannabinoid mechanism of action

18:30 Cannabis and cannabinoid products available

20:20 Synthetic THC (dronabinol)

21:46 How “recommending” cannabis and dispensaries work

25:46 Conditions that respond to medical cannabis

29:15 Potential harms of medical cannabis

34:51 Future directions of cannabinoid medicine research

37:24 Cannabis induced hyperemesis syndrome

39:00 Possible lung cancer risk

40:12 Take home points

42:54 The Curbsiders recap and share their views on the medical cannabis controversy

49:40 Outro

Transcript

Click on a timestamp to play from that location

0:00.0	They then take the letter to the dispensary.
0:03.6	I have no idea what products the dispensary has.
0:06.7	I say ask the so-called Bud tender, but they, that's what they're called, what they feel
0:16.2	would work best in your situation and try it.
0:20.0	Yeah.
0:21.0	Do the Bud tenders have special training or?
0:23.0	I don't know.
0:24.0	I'm almost really asking that.
0:25.0	Welcome back to the Curbsiders, the Internal Medicine Podcast that uses expert interviews
0:45.5	to bring you clinical pearls and practice changing knowledge.
0:48.8	I'm Dr. Matthew Wato here with multiple co-hosts.
0:52.1	Dr. Stewart Kent Brigham.
0:53.6	Hello.
0:54.6	Dr. Paul Williams.
0:55.6	Hi, guys.
0:57.0	And Dr. Molly Hoybine.
0:58.2	Hi, thanks for having me back.
1:00.3	Yeah, Molly.
1:01.3	We're so glad to have you back on the show.
1:03.0	This is awesome.
1:04.0	Thanks for finding us such a great guest for tonight, Molly.
1:06.4	Yeah, it was glad to be with available and willing to join us.
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from The Curbsiders Internal Medicine Podcast, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of The Curbsiders Internal Medicine Podcast and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.